Eargo, Inc. (EAR)

2.6021 -0.0029 (-0.11%) As of 03:00PM EST. Market open.

Eargo, Inc.

2665 North First Street
Suite 300
San Jose, CA 95134
United States
650 351 7700
https://eargo.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 243

Key executives

Name	Title	Pay	Exercised	Year born
Mr. William H. Brownie	Interim CEO & COO	625.2k	N/A	1967
Mr. Adam Laponis	Chief Financial Officer	586.2k	N/A	1976
Mr. Daniel Shen	Co-Founder and Chief Clinical & Science Officer	N/A	N/A	N/A
Mr. Mark Thorpe	Chief Accounting Officer	N/A	N/A	1968
Mr. Tim Trine Ph.D.	Chief Technology Officer	N/A	N/A	N/A
Ms. Christy La Pierre	Chief Legal Officer & Secretary	N/A	N/A	N/A
Ms. Tricia Burchell	Senior Vice President of People Operations	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. It markets and sells hearing aids. The company sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California.

Corporate governance

Eargo, Inc.’s ISS governance QualityScore as of 28 November 2023 is 10. The pillar scores are Audit: 10; Board: 10; Shareholder rights: 7; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.